Skip to main content
. 2018 Apr 26;62(5):e02024-17. doi: 10.1128/AAC.02024-17

FIG 7.

FIG 7

In vivo efficacy data for ZAC989 and ZAC307 in a 3-day candidiasis kidney burden model. Dosing with and without pretreatment (day −1) yields the same CFU reduction for ZAC307. #, no pretreatment in this arm; *, P < 0.05 compared to infected untreated control group by one-way analysis of variance (ANOVA).